Diverticulitis Market is segemented By Treatment (Medical Therapy, Surgical Procedures), By Diagnosis Method (Imaging Tests, Laboratory Tests), By End User (Hospitals, Am ....
Market Size in USD
CAGR7.2%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 7.2% |
Market Concentration | Medium |
Major Players | Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Allergan (now part of AbbVie), Bayer AG, Johnson & Johnson, Pfizer Inc. |
The diverticulitis market is estimated to be valued at USD 2.68 Bn in 2024 and is expected to reach USD 4.36 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. The aging population is more prone to develop diverticulitis, as it often occurs in older age groups. This increases the risk of complications associated with the disease.